National Institutes of Health grant notices posted in 2023, now closed
720 National Institutes of Health grant notices posted on Grants.gov in 2023 that have closed, with their numbers and dates.
- PAR-24-101: NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
- PAR-24-075: Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
- RFA-AA-24-002: High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R41/R42 Clinical Trials Not Allowed)
- RFA-AA-24-001: High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R43/R44 Clinical Trials Not Allowed)
- PAR-24-076: Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
- RFA-DC-24-007: NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
- RFA-AI-24-002: Research Initiative for Vaccine and Antibiotic Allergy (UG3/UH3 Clinical Trial Not Allowed)
- PAR-24-074: NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
- RFA-DA-25-007: Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)
- RFA-DA-25-008: Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R21 Clinical Trial Not Allowed)
- PAR-24-080: Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
- PAR-24-083: NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
- PAR-24-084: Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
- PAR-24-086: Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
- PAR-24-087: Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
- PAR-24-090: Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
- PAR-23-315: Geroscience Course (R25 Independent Clinical Trial Not Allowed)
- RFA-NR-24-003: Clinical-Community Linkages to Address Unmet Social Needs and Adverse Social Determinants of Health to Advance Health Equity among Populations Experiencing Health Disparities: The Bridge-to-Care Initiative (R01 Clinical Trial Optional)
- RFA-DA-25-028: Development of Clinical Outcome Assessments as New FDA-Qualified Drug Development Tools to Accelerate Therapeutics Development for Opioid and Stimulant Use Disorders (UG3/UH3 Clinical Trial Optional)
- PAR-24-055: Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)
- PAR-24-072: Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- PAR-24-085: National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- RFA-CA-24-016: Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
- RFA-CA-24-017: Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
- RFA-CA-24-018: Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
- RFA-CA-24-019: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
- RFA-AI-23-065: Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)
- PAR-24-088: Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
- RFA-AI-23-068: Bat Immunology Network Research Projects (R01 Clinical Trial Not Allowed)
- RFA-AI-23-069: Bat Immunology Network Research Resource Program (U24 Clinical Trial Not Allowed)
- PAR-24-082: Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
- PAR-23-319: Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional)
- PAR-24-092: Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
- PAR-24-091: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
- PAR-24-038: Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed)
- RFA-ES-23-012: Undergraduate Research Education Program (UP) to Enhance Diversity in the Environmental Health Sciences (R25 Clinical Trial Not Allowed)
- PAR-23-318: Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
- RFA-CA-24-021: Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)
- RFA-DA-25-009: Interplay of Autophagy Regulated Cell Death and HIV Pathogenesis in Substance Use Disorders (R01 Clinical Trial Not Allowed)
- RFA-DA-25-010: Interplay of Autophagy Regulated Cell Death and HIV Pathogenesis in Substance Use Disorders (R21 Clinical Trial Not Allowed)
- RFA-DA-25-023: Integrated Functional Mapping and Molecular Profiling of Cell Ensembles Encoding the Effects of Addictive Substances in Rodents (R01 Clinical Trial Not Allowed)
- RFA-MH-25-140: Streamlining mental health interventions for youth living with HIV in Low- and Middle-Income Countries (R01 Clinical Trial Optional)
- PAR-24-081: Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed)
- RFA-TR-24-001: Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
- PAR-24-066: NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)
- PAR-24-071: Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
- RFA-DK-23-021: Cardiovascular Repository Type 1 Diabetes (CARE-T1D) Consortium (U01 Clinical Trial Not Allowed).
- RFA-DK-25-001: Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
- RFA-HL-25-001: Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
- PAR-24-077: Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)
- RFA-CA-24-009: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- RFA-AG-25-006: Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)
- PAR-24-048: Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)
- RFA-CA-24-008: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- RFA-CA-24-010: Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- RFA-CA-24-011: Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- RFA-CA-24-012: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
- RFA-CA-24-013: Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
- RFA-CA-24-014: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
- RFA-CA-24-015: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional)
- PAR-24-041: Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)
- RFA-MH-25-115: BRAIN Initiative: Marmoset Colonies for Neuroscience Research (U24 Clinical Trials Not Allowed)
- RFA-MH-25-116: BRAIN Initiative: Marmoset Coordination Center (U24 Clinical Trials Not Allowed)
- RFA-MH-24-106: Early Psychosis Intervention Network (EPINET) Data Coordinating Center (U24 Clinical Trial Not Allowed)
- PAR-23-311: NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
- PAR-24-044: NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
- RFA-RM-23-014: Short Courses to Promote the Broad and Rigorous Use of Common Fund Data (R25 Clinical Trial Not Allowed)
- RFA-DA-24-042: BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Optional)
- RFA-MH-24-105: Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional)
- PAR-24-070: Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Not Allowed}
- PAR-24-073: Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Required)
- PAR-24-069: NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32)
- PAR-24-042: Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
- PAR-24-067: Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
- PAR-24-068: Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
- PAR-24-040: Modules for Enhancing Biomedical Research Workforce Training (R25 - Independent Clinical Trial Not Allowed)
- RFA-NS-24-029: Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- RFA-TR-23-018: Miniaturization and Automation of Tissue Chip Systems (MATChS) (UT1/UT2 - Clinical Trial Not Allowed)
- RFA-TR-23-017: Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)
- PAR-24-065: NHLBI Program Project Applications (P01 Clinical Trials Optional)
- RFA-DA-25-030: Adolescent Overdose Prevention and SUD Treatment Initiative (R21 - Clinical Trial Not Allowed)
- RFA-DA-25-031: Adolescent Overdose Prevention and SUD Treatment Initiative (R34 - Clinical Trial Optional)
- PAR-24-061: Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R25 Independent Clinical Trial Not Allowed)
- PAR-24-031: Initiative for Maximizing Student Development (IMSD) (T32)
- PAR-24-032: Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)
- PAR-24-052: Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
- RFA-DC-24-004: In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
- RFA-DC-24-005: Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
- RFA-DA-24-036: Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only)
- RFA-DA-25-027: The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
- RFA-DA-25-029: National Drug Early Warning System Coordinating Center (U01 Clinical Trial Not Allowed)
- PAR-23-286: NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
- PAR-23-287: NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
- PAR-23-288: NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
- PAR-24-054: Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
- PAR-24-062: Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)
- RFA-HG-23-048: Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
- RFA-HG-23-032: Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
- RFA-HG-23-033: Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
- PAR-24-036: Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
- PAR-24-053: Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)
- PAR-24-035: Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
- RFA-OD-24-006: Coordinating Center to Support Multi-Sectoral Preventive Interventions that Address Social Determinants of Health in Populations that Experience Health Disparities (U24, Clinical Trial Not Allowed)
- PAR-24-049: NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- PAR-23-282: NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
- RFA-NS-24-028: BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)
- PAR-24-043: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
- RFA-CA-23-043: Single Source: AIDS and Cancer Specimen Resource (ACSR; UM1 Clinical Trials Not Allowed)
- RFA-HD-25-008: Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)
- RFA-DA-25-058: Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional)
- RFA-DA-25-022: Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional)
- RFA-NR-24-002: Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed)
- RFA-RM-24-001: IND-enabling Studies for Platform Clinical Trials of Genome Editing in Multiple Diseases (U01 Clinical Trial Not Allowed)
- PAR-24-039: Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
- RFA-MH-24-180: Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)
- PAR-23-313: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
- PAR-24-063: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
- RFA-MH-24-181: Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)
- PAR-23-314: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
- RFA-NS-24-019: HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
- RFA-DA-25-021: Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional)
- PAR-23-293: Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- PAR-23-294: Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- PAR-23-295: Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- RFA-AT-24-006: Resource Center for Cannabis and Cannabinoid Research (U24 Clinical Trial Not Allowed)
- RFA-AI-23-061: Long-Acting Drug Delivery Systems for ART Optimization in Children Living with HIV-1 II (LADDS II) (R61/R33 Clinical Trial Not Allowed)
- RFA-AI-23-060: Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed)
- PAS-24-057: Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R21-Clinical Trial Not Allowed)
- PAS-24-058: Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R01-Clinical Trial Not Allowed)
- RFA-DA-25-051: Tools for Decentralized Clinical Trials for Substance Use Disorder (R41/R42 Clinical Trials Optional)
- RFA-DA-25-052: Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional)
- RFA-DK-25-002: Single Source for continuation of the Human Pancreas Analysis Program for Type-2 Diabetes (HPAP-T2D) (U01 Clinical Trial Not Allowed)
- RFA-AI-23-059: Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs) (U01 Clinical Trial Not Allowed)
- PAR-24-046: Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
- PAR-24-050: NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
- PAR-24-051: NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
- RFA-AG-24-040: Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed)
- RFA-DK-25-003: Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)
- RFA-HD-24-015: HEAL Initiative: Limited Competition: Data Coordinating Center for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (U24 Clinical Trial Not Allowed)
- RFA-HD-24-014: HEAL Initiative: Limited Competition: Clinical Centers for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (UG1 Clinical Trial Not Allowed)
- PAR-24-059: Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)
- RFA-NS-24-013: Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required)
- RFA-OD-24-003: Down Syndrome Cohort Research Sites (DS-CRS) for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U01 Clinical Trial Not Allowed)
- RFA-OD-24-004: Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed)
- RFA-OD-24-005: Down Syndrome Clinical Cohort Coordinating Center (DS-4C) for the INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) (U54 Clinical Trial Not Allowed)
- RFA-MD-24-001: Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional)
- RFA-AA-23-004: Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional)
- PAR-24-045: Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
- RFA-DA-25-012: Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)
- RFA-DA-25-013: Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)
- RFA-CA-24-006: Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional)
- RFA-DA-24-030: Applying Imaging Pipelines for Spatial Characterization of Cellular Interactions in HIV-related CNS Pathology and/or Substance Use (R61/R33 Clinical Trial Not Allowed)
- PAR-24-028: Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed)
- PAR-23-303: Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
- PAR-23-304: Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
- RFA-DK-23-004: Human Islet Research Network - Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD) (UG3/UH3 Clinical Trial Not Allowed)
- PAR-24-047: Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
- RFA-EB-23-006: Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
- RFA-AI-23-057: Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed)
- RFA-DA-25-011: Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R01 Clinical Trial Not Allowed)
- PAR-23-228: National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)
- PAR-24-033: Limited Competition: Development and Renovation of Facilities for Expanding the Breeding Capacity of Specific Pathogen Free Non-Human Primates to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed)
- PAR-23-306: Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
- PAR-23-308: Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
- RFA-OD-24-002: R25 for Short Courses on Techniques for Measuring Intimate Partner Violence (IPV) in Different Populations (R25 Clinical Trial Not Allowed)
- PAR-24-037: HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
- RFA-DA-25-059: Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
- RFA-OD-24-001: Career Enhancement Award to Advance the Study of Intimate Partner Violence (IPV) in the Context of Maternal Morbidity and Mortality Research (K18 Clinical Trial Not Allowed)
- RFA-CA-23-041: Single Source: Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC; U24 Clinical Trial Not Allowed)
- RFA-CA-23-040: Pre-Cancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed)
- RFA-CA-23-039: Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed)
- PAR-23-221: Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)
- PAR-23-222: Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed)
- RFA-DA-24-032: Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required)
- RFA-DA-24-033: Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional)
- RFA-DA-24-034: Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Basic Experimental Studies with Humans Required)
- PAR-23-276: Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
- RFA-DE-24-006: NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)
- RFA-DA-25-047: Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
- RFA-DA-25-048: Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
- RFA-DA-24-031: Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional)
- PAR-23-309: Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
- RFA-NS-23-032: Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
- PAR-23-301: Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
- PAR-23-302: Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
- RFA-AI-23-054: Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed)
- RFA-DA-24-005: Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Clinical Trials Optional)
- RFA-DA-24-006: Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Basic Experimental Studies with Humans (BESH) Required)
- RFA-MD-24-003: Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)
- RFA-DA-24-066: HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional)
- RFA-DA-24-067: HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional)
- PAR-23-284: Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
- RFA-DA-25-015: Single Source: Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed)
- RFA-DA-25-016: Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed)
- RFA-DA-25-017: Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed)
- PAR-23-277: Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
- PAR-23-278: Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
- RFA-DA-24-025: NIDA REI: Training a Diverse Data Science Workforce for Addiction Research (R25 Clinical Trial Not Allowed)
- RFA-DA-24-026: NIDA REI: Academic Research Enhancement Award (AREA) Training a Diverse Data Science Workforce for Addiction Research (R15 Clinical Trial Not Allowed)
- PAR-23-296: Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)
- PAR-23-297: Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
- RFA-MH-24-330: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R01 Clinical Trial Optional)
- RFA-MH-24-331: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R21 Clinical Trial Optional)
- RFA-MH-24-332: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional)
- PAR-23-305: Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)
- PAR-23-307: Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional)
- RFA-EY-23-001: BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
- RFA-AI-23-056: Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed)
- PAR-23-275: NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
- RFA-RM-23-016: Consortium Organization and Data Collaboration Center (CODCC) for the Human Virome Program (HVP) (U24 Clinical Trial Not Allowed)
- RFA-RM-23-017: Human Virome Program: Characterization of functional interactions between viruses and human and microbial hosts (U01 Clinical Trial Not Allowed)
- RFA-RM-23-018: Human Virome Program: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed)
- RFA-RM-23-019: Human Virome Characterization Centers (U54 Clinical Trial Not Allowed)
- PA-23-271: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
- PAR-23-298: Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- PAR-23-299: Intervention Research to Improve Native American Health (R21 Clinical Trials Optional)
- PAR-23-285: Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
- RFA-DA-25-003: Cohort Studies of HIV/AIDS and Substance Use (U01 Clinical Trial Not Allowed)
- PAR-23-300: Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
- RFA-ES-23-010: Center for Exposome Research Coordination to Accelerate Precision Environmental Health (U24 Clinical Trial Not Allowed)
- RFA-AA-23-005: HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R01 Clinical Trial Optional)
- RFA-AA-23-006: HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R34 Clinical Trial Optional)
- RFA-MH-24-320: Approaches to Identifying Preteen Suicide Risk and Protective Factors (R01 Clinical Trial Not Allowed)
- RFA-MH-24-322: Data Coordinating Center for Approaches to Identifying Preteen Suicide Risk and Protective Factors (U24 Clinical Trial Not Allowed)
- RFA-DK-23-018: Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Scientific and Data Coordinating Center (U24 Clinical Trial Optional)
- RFA-DK-23-516: Single Source for the Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating Center (U24 Clinical Trial Required)
- RFA-DK-23-515: Limited Competition for the Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Clinical Centers (U01 Clinical Trial Required)
- PAR-23-292: Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
- PA-23-261: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
- PA-23-262: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
- RFA-DK-23-017: Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers (U01 Clinical Trial Required)
- RFA-HL-24-015: Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed)
- RFA-HL-24-016: Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordinating Center (U24- Clinical Trial Not Allowed)
- RFA-AG-24-033: State Dementia Care Research Center (U54 Clinical Trial Not Allowed)
- RFA-AG-24-034: High-Priority Behavioral and Social Research Networks??(R24 Clinical Trial Optional)
- RFA-AG-24-035: Limited Competition: The Harmonized Cognitive Assessment Protocol (HCAP) Network (U24 Clinical Trial Not Allowed)
- RFA-NR-24-001: Firearm Injury Prevention in Community Healthcare Settings (R01 Clinical Trial Optional)
- RFA-NS-24-023: HEAL INITIATIVE: Development and validation of remote or patient wearable device derived objective biosignatures or functional assessments to monitor pain for use as endpoints in clinical trials (UG3/UH3 - Clinical Trial Optional)
- RFA-MH-25-126: Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional)
- RFA-MH-25-125: Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional)
- RFA-MH-24-190: BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
- PAR-23-289: Diagnostic Centers of Excellence for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed)
- RFA-AI-23-055: Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed)
- RFA-MH-25-145: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed)
- PAR-23-236: Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed)
- PAR-23-237: Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed)
- RFA-HG-23-002: Broadening Opportunities for Computational Genomics and Data Science Education (UE5 Clinical Trial Not Allowed)
- RFA-DE-24-003: Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed)
- RFA-MH-24-235: Biotypes of CNS Complications in People Living with HIV (P01 Clinical Trial Not Allowed)
- RFA-DE-24-004: Developing Salivary Components as Therapeutics for Oral Health (R01 Clinical Trial Not Allowed)
- RFA-DE-24-005: Developing Salivary Components as Therapeutics for Oral Health (R21 Clinical Trial Not Allowed)
- PAR-22-268: Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)
- PAR-23-257: IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional)
- PAR-23-241: IDeA Clinical and Translational Research Network (CTR-N) Award (P50 - Clinical Trial Optional)
- RFA-AG-24-030: Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional)
- RFA-AG-24-031: Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional)
- RFA-MH-24-160: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R01 Clinical Trial Optional)
- RFA-MH-24-161: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R21 Clinical Trial Optional)
- RFA-MH-24-162: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional)
- RFA-AG-24-027: Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed)
- RFA-CA-24-007: Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial Required)
- PAR-23-280: Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- PAR-24-027: Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
- RFA-RM-23-012: Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional)
- PAR-23-279: Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- RFA-AG-24-046: Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed)
- PAR-23-274: Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
- PA-23-263: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)
- RFA-DA-25-018: Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
- RFA-DA-24-068: HEAL Initiative: Justice Community Overdose Innovation Network (JCOIN) - Phase II Methodology and Advanced Analytics Resource Center (UM1 Clinical Trial Not Allowed)
- RFA-DA-24-069: HEAL Initiative: Justice Community Overdose Innovation Network (JCOIN) - Phase II Coordination and Translation Center (U2C Clinical Trial Optional)
- RFA-CA-23-042: The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
- PAR-23-281: Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
- PAR-23-253: Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
- RFA-HD-24-012: HEAL Initiative: HEAL KIDS (Knowledge, Innovation and Discovery Studies) Pain Program Resource and Data Center (U24 Clinical Trial Not Allowed)
- RFA-HD-24-011: HEAL Initiative: HEAL KIDS (Knowledge, Innovation and Discovery Studies) Pain: Acute Pain Clinical Trials Program (U01 Clinical Trial Required)
- RFA-HD-24-010: National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional)
- PA-23-260: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
- PA-23-272: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)
- PAR-23-258: Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional)
- RFA-NS-24-027: VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed)
- RFA-NS-23-030: NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed)
- PAR-23-270: Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
- PAR-23-244: Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- RFA-AG-24-042: NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional)
- RFA-AG-24-043: NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional)
- RFA-HD-24-007: Understanding and Mitigating Health Disparities experienced by People with Disabilities caused by Ableism (R01 Clinical Trial Optional)
- PAR-24-029: Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
- RFA-NS-24-007: Community-Engaged Health Equity Research in Neuroscience Initiative (R34 CT Not Allowed)
- PAR-23-229: NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
- RFA-AG-24-041: Neural and Non-Neural Mechanisms Underlying Gait as a Preclinical Marker for Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional)
- PAR-23-264: Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
- RFA-NS-24-006: Community-Engaged Health Equity Research in Neuroscience Initiative (R01 CT Not Allowed)
- PAR-23-273: Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
- RFA-NS-24-021: HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional)
- PAR-23-245: Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
- RFA-AG-24-045: Elucidating Variability of Physiologic and Functional Responses to Exercise Training in Older Adults (R01 Clinical Trial Required)
- PAR-23-249: Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
- PAR-23-250: Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
- PAR-23-251: Alcohol Health Services Research (R01 Clinical Trial Optional)
- PAR-23-252: Alcohol Health Services Research (R34 Clinical Trial Optional)
- RFA-AG-24-028: Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R01 Clinical Trial Not Allowed)
- RFA-AG-24-029: Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R21 Clinical Trial Not Allowed)
- PAR-23-242: NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
- PAR-23-243: NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
- PAR-23-259: Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- PAR-23-256: Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)
- PAR-23-254: Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- PAR-23-255: Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- RFA-HG-23-041: Network of Genomics-Enabled Learning Health Systems (gLHS) Clinical Sites (U01 Clinical Trial Required)
- RFA-HG-23-042: Network of Genomics-Enabled Learning Health Systems (gLHS) Coordinating Center (U01 Clinical Trials Required)
- PAR-23-240: Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
- PAR-23-248: Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
- RFA-OD-23-021: Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)
- RFA-NS-24-026: Validating digital health technologies for monitoring biomarkers in ADRD clinical trials (R61/R33 - Clinical Trials Optional)
- RFA-HD-24-009: Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATCH-IN) Implementation Science Coordinating Center (UM2 Clinical Trial Optional)
- RFA-DA-25-001: Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
- RFA-DA-25-002: Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
- RFA-DK-23-001: A Consortium for Gut-Brain Communication in Parkinsons Disease (U24 Clinical Trial not allowed)
- RFA-DK-22-036: A Consortium for Gut-Brain Communication in Parkinsons Disease (U01 Clinical Trial Not Allowed)
- PAR-23-235: National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
- RFA-AG-24-044: Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required)
- RFA-RM-23-015: Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
- RFA-NS-24-024: Role of Environmental Stress in the Health Inequities of Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed)
- RFA-NS-24-014: NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed)
- RFA-HL-24-008: The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R01 Clinical Trial Optional)
- RFA-HL-24-009: The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R34 Clinical Trial Optional)
- RFA-AT-24-004: NIH-DoD-VA Pain Management Collaboratory ? Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required)
- PAR-23-246: Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
- RFA-AG-24-050: Health Equity and the Cost of Novel Treatments for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)
- RFA-DA-24-063: HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed)
- RFA-DA-24-064: HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
- PAR-23-238: Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
- PAR-23-239: Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
- RFA-DA-25-014: Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
- RFA-DA-25-019: Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required)
- RFA-DA-25-020: Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
- RFA-CA-23-036: Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed)
- RFA-CA-23-037: Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)
- RFA-DK-22-512: Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Participating Clinical Centers (U01 Clinical Trial Not Allowed)
- RFA-HL-24-006: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clinical Trial Not Allowed)
- RFA-HL-24-007: Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordinating Center (U24- Clinical Trial Not Allowed)
- RFA-HL-24-012: Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed)
- RFA-EB-23-007: Single Source: NIH Blueprint for Neuroscience Research: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed)
- RFA-DK-22-513: Single Source for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed)
- RFA-AT-24-005: Research Resource for Systematic Reviews of Complementary and Integrative Health (R24 Clinical Trial Not Allowed)
- PA-23-231: PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- PA-23-230: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
- PA-23-232: PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
- PA-23-233: PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
- RFA-MH-24-150: Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required)
- RFA-MH-24-151: Single Source: Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical Trial Data Processing, Analysis, and Coordination Center (U24 Clinical Trial Not Allowed)
- PAR-23-219: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
- PAR-23-220: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
- RFA-RM-23-013: Partnerships With Common Fund Data Ecosystem Resources (U24 Clinical Trial not Allowed)
- PAR-23-216: Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)
- RFA-EB-23-003: Single Source : NIH Blueprint for Neuroscience Research: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed)
- RFA-AG-24-039: Development and Validation of Harmonized Methodologies to Measure NAD+ and Related Metabolites in Clinical Trials (U01 Clinical Trial Required)
- RFA-TR-23-016: Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- RFA-AG-24-048: Primary Care-Based Screening Tool and Intervention Development for the Detection and Prevention of Abuse and Neglect in Older and Vulnerable Adults With, or at Risk for, Mild Cognitive Impairment and AD/ADRD (R61/R33 Clinical Trial Required)
- RFA-ES-23-011: Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
- RFA-OD-23-018: ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed)
- PAR-24-024: Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
- PAR-24-025: Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
- PAR-24-026: Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
- PAR-24-023: Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
- RFA-MD-24-002: Youth Violence Prevention Interventions (R01 - Clinical Trial Required)
- RFA-MH-24-100: Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment (R21/R33 Clinical Trial Not Allowed)
- PAR-23-234: Data Analysis and Coordination Center for the PsychENCODE Consortium (U24 Clinical Trial Not Allowed)
- PAR-23-215: Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
- PAR-23-225: HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
- RFA-AT-24-002: Limited Competition: NIH-DoD-VA Pain Management Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed)
- PA-23-189: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
- RFA-CA-23-026: Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional)
- RFA-CA-23-027: Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)
- RFA-AI-23-039: Advancing Development of Diagnostics for Congenital and Adult Acquired Syphilis (R21 Clinical Trial Not Allowed)
- PAR-23-205: NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed)
- PAR-23-200: NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
- RFA-NS-24-025: Analysis of data in the COVID-19 Neuro Databank-Biobank (R03 - Clinical Trial Not Allowed)
- RFA-NS-24-009: Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed)
- RFA-OD-23-019: Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
- RFA-OD-23-020: Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36)
- RFA-ES-23-009: CCRP Initiative: Chemical Threat Agent Exposure Resource and Coordination Core (ExRC) (U2C Clinical Trial Not Allowed)
- RFA-HG-23-027: Center for ELSI Resources and Analysis (U24 Clinical Trial Not Allowed)
- RFA-HG-23-024: Limited Competition: High Quality Reference Genomes (UM1 Clinical Trial Not Allowed)
- RFA-HG-23-025: Limited Competition: Human Pangenome Coordinating Center (U41) Clinical Trial Not Allowed
- RFA-HG-23-026: Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
- PAR-24-210: Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)
- RFA-HL-24-010: The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional)
- RFA-HL-24-011: The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed)
- PAR-23-195: Simultaneous and Synergistic Multi-Target Validation for Alzheimers Disease-Related Dementias (R61/R33 Clinical Trial not allowed)
- RFA-MH-24-280: BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
- PAR-23-194: Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
- RFA-DK-23-014: NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed)
- PAR-23-213: Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed)
- PAR-23-218: Development and Characterization of Experimental models of post-TBI ADRD (R01 - Clinical Trial Not Allowed)
- PAR-23-207: Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
- PAR-23-208: Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
- PAR-23-178: NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
- PAR-23-197: NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
- RFA-AI-23-038: Development of Software for Data Science in Infectious and Immune-Mediated Diseases Research (U01 Clinical Trial Not Allowed)
- RFA-AG-24-047: Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
- RFA-AG-24-037: Limited Competition: National Health and Aging Trends (NHATS) and National Study of Caregiving (NSOC) (U01 Clinical Trial Not Allowed)
- RFA-AI-23-027: Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Not Allowed)
- RFA-AG-24-025: Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional)
- RFA-AG-24-026: Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional)
- RFA-AT-24-003: HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)
- PAR-23-199: ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
- RFA-DK-23-008: Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed)
- PAR-23-214: Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed)
- RFA-HG-23-018: Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
- RFA-HG-23-017: Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
- PAR-23-203: Limited Competition: Collaborative Partnership to Advance Global Health Research (U01 Clinical Trial Not Allowed)
- PAR-23-198: NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
- PAR-23-206: NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed)
- PAR-23-166: Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)
- RFA-MH-24-120: Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional)
- RFA-AG-24-032: Enhancing Use of Harmonized Cognitive Assessment Protocol Data?(R01 Clinical Trial Not Allowed)
- RFA-DK-23-019: Integration of Novel Measures for Improved Classification of Type 2 Diabetes (U01, Clinical Trials Not Allowed)
- RFA-DK-23-020: Integration of Novel Measures for Improved Classification of Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed)
- RFA-CA-23-024: Limited Competition: Cooperative Human Tissue Network (CHTN; UM1 Clinical Trial Not Allowed)
- RFA-DK-23-013: Undergraduate Summer Research Education in Kidney, Urologic, and Hematologic Diseases (R25 Clinical Trial Not Allowed)
- PAR-23-201: NEI Collaborative Clinical Vision Research Project: Resource Center Grant (UG1 Clinical Trial Required)
- PAR-23-204: NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
- PAR-23-126: Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)
- PAR-23-184: Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
- PAR-23-209: NEI Collaborative Clinical Vision Research: Chair's Grant (UG1-Clinical Trial Required)
- PAR-23-181: Accelerating Behavioral and Social Science through Ontology Development and Use: Dissemination and Coordination Center (U24) Clinical Trial Not Allowed
- PAR-23-182: Accelerating Behavioral and Social Science through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed)
- RFA-AA-23-001: Specialized Alcohol Research Centers (P50 Clinical trial Optional)
- RFA-AA-23-002: Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
- PAR-23-211: Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed)
- PAR-23-212: Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed)
- RFA-DK-22-510: Limited Competition for the NIDDK Short-Term Research Experience Program to Unlock Potential (STEP-UP) (R25 Clinical Trial Not Allowed)
- RFA-DA-24-017: Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R41/R42 Clinical Trial Optional)
- RFA-DA-24-018: Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R43/R44 Clinical Trial Optional)
- RFA-MD-23-011: NIMHD Centers of Excellence in Investigator Development and Community Engagement (P50 - Clinical Trial Optional)
- PAR-23-193: Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
- RFA-NS-24-003: Assessment of TBI-related ADRD Pathology Related to Cognitive Impairment and Dementia Outcomes (U01 - Clinical Trial Not Allowed)
- PAR-23-183: NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
- RFA-AG-24-036: Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)?
- RFA-AG-24-038: Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)?
- RFA-HD-24-005: Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed)
- PAR-23-151: Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed)
- RFA-DA-24-024: Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required)
- RFA-DA-24-028: Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed)
- RFA-DA-24-029: Advancing Psychedelics Research for Treating Addiction (R61/R33 Basic Experimental Study with Humans Required)
- RFA-DA-24-016: Patient Engagement Resource Centers to Inform SUD Treatment Services Research (R24 Clinical Trial Optional)
- PAR-23-185: Alcohol Health Services Research (R01 Clinical Trial Optional)
- PAR-23-187: Alcohol Treatment and Recovery Research (R01 Clinical Trial Required)
- PAR-23-186: Alcohol Health Services Research (R34 Clinical Trial Optional)
- PAR-23-188: Alcohol Treatment and Recovery Research (R34 Clinical Trial required)
- RFA-NS-24-010: Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)
- RFA-NS-23-027: Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)
- RFA-AI-23-029: Analyzing Early Events in TB and TB/HIV Infection for Interventional Targets (R01 Clinical Trial Not Allowed)
- RFA-AI-23-032: Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed)
- RFA-AG-24-021: Understanding Gene-Environment Interactions in Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
- RFA-AG-24-022: Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed)
- RFA-AG-24-023: Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
- RFA-DK-23-009: Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Biostatistics Research Center (U01 Clinical Trial Not Allowed)
- RFA-DK-23-010: Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Clinical Centers (U01 Clinical Trial Not Allowed)
- PAS-23-172: HIV Prevention and Alcohol (R34 Clinical Trials Optional)
- PAS-23-173: HIV Prevention and Alcohol (R01 Clinical Trials Optional)
- PAR-23-174: Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
- PAR-23-177: Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
- RFA-AG-24-017: Limited Competition: Renewal of the Longevity Consortium (U19 Clinical Trial Not Allowed)
- PAR-23-190: Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
- PAR-23-191: HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
- PAR-23-180: Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
- RFA-NS-24-015: HEAL Initiative Partnerships to Advance INterdisciplinary (PAIN) Training in Clinical Pain Research: The HEAL PAIN Cohort Program (T90/R90 Independent Clinical Trial Not Allowed)
- RFA-MH-23-295: BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
- RFA-OD-23-016: INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
- RFA-MH-23-290: BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
- PAR-23-142: NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required)
- PAR-23-143: NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed)
- RFA-AI-23-024: Sex Differences in Radiation Research: Models, Underlying Pathways, Biomarkers of Injury, and Medical Countermeasure Responses (U01 Clinical Trial Not Allowed)
- RFA-DK-23-012: Human Liver Tissue and Hepatocytes Resource-Related Research Project (R24 Clinical Trial Not Allowed)
- RFA-OD-23-017: Tobacco Regulatory Science (R01 Clinical Trial Optional)
- RFA-NS-24-011: Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional)
- RFA-DA-24-019: Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (R34 Clinical Trial Not Allowed)
- RFA-OD-23-050: Emergency Award: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed)
- RFA-OD-23-051: Emergency Award: RADx-UP Dissemination and Implementation (D and I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)
- RFA-NS-24-020: NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)
- RFA-RM-23-020: Limited Competition: Molecular Transducers of Physical Activity Bioinformatics Center (U24 Clinical Trial Not Allowed)
- RFA-RM-23-021: Limited Competition: Molecular Transducers of Physical Activity Chemical Analysis Sites (U24 Clinical Trial Not Allowed)
- PAR-23-175: NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed)
- RFA-EB-23-005: Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)
- PAR-23-192: Biological Testing Facility (X01 Clinical Trial Not Allowed)
- RFA-NS-23-028: HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional)
- RFA-CA-23-038: Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed)
- RFA-AG-24-016: Nursing Home EXplanatory Clinical Trials Network (NEXT) (U24 Clinical Trial Required)
- RFA-NS-23-024: BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)
- RFA-NS-23-023: BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed)
- RFA-NS-23-025: BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional)
- PAR-23-179: Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
- PAR-23-145: Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
- RFA-DA-24-039: NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed)
- RFA-CA-23-034: SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
- RFA-CA-23-035: Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)
- RFA-CA-23-029: Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed)
- PAR-23-149: Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed)
- PAR-23-150: Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required)
- RFA-CA-24-005: Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
- PAR-23-169: Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
- RFA-AI-23-026: Synthetic Nucleic Acid Platforms for HIV-1 (SNAPH): (R61/R33 Clinical Trial Not Allowed)
- PAR-23-144: STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed)
- PAR-23-161: Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)
- PAR-23-170: Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
- RFA-TR-23-011: Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
- RFA-DA-24-015: Ending the HIV Epidemic: Focus on Justice Populations with SUD (R61/R33 Clinical Trial Required)
- RFA-DA-24-022: Ending the HIV Epidemic: Resource Center to Engage Justice-Involved Populations (U24 Clinical Trial Optional)
- RFA-DA-24-023: Ending the HIV Epidemic: Focus on Justice Populations with SUD-Data Coordination and Dissemination Center (UM1 Clinical Trial Optional)
- PAR-23-267: Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
- PAR-23-268: Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
- RFA-HG-23-005: Data Integration and Statistical Analysis Methods (DISAM) (U01 Clinical Trial Not Allowed)
- RFA-DA-24-020: Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed)
- RFA-DA-24-021: Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required)
- RFA-DA-24-038: Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)
- RFA-NS-23-026: BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
- PAR-23-156: Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
- PAR-23-168: Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
- RFA-ES-23-001: Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
- RFA-MH-23-105: Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional)
- RFA-MH-23-106: Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH): Data Coordinating Center (U24 Clinical Trial Not Allowed)
- RFA-AI-23-023: International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
- RFA-MH-23-330: BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)
- RFA-MH-23-331: BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
- RFA-TR-23-010: Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)
- PAR-23-098: Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
- PAR-23-160: Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
- PAR-23-159: Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
- RFA-MH-23-270: BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
- PAR-23-155: Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
- PAR-23-154: Development and Validation of Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)
- PAR-23-119: Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
- PAR-23-163: Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
- PAR-23-157: Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
- PAR-23-158: Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
- RFA-AI-23-028: Fundamental Research to Understand the Mechanisms of Neurotropic Virus-mediated Disease (R01 Clinical Trial Not Allowed)
- RFA-MH-23-265: Developing Measures to Advance Quality in Mental Health Care Services (R01 Clinical Trial Not Allowed)
- PAR-23-164: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
- PAR-23-165: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed)
- RFA-DE-24-001: Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R01 Clinical Trial Not Allowed)
- RFA-DE-24-002: Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R21 Clinical Trial Not Allowed)
- RFA-AR-24-003: Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
- RFA-CA-23-033: Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)
- PAR-23-171: Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
- PAR-23-114: Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)
- PAR-23-141: Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional)
- PAR-23-137: NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
- RFA-ES-23-006: Strategies for Responsibly Reporting Back Environmental Health and Non-Genomic Research Results (R01 Clinical Trial Optional)
- RFA-NS-24-022: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional)
- PAR-23-162: NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
- RFA-MH-23-110: BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
- RFA-MH-23-130: BRAIN Initiative: Brain Behavior Quantification and Synchronization Data Coordination and Artificial Intelligence Center (U24 Clinical Trial Optional)
- RFA-DC-24-001: BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required)
- RFA-MH-23-300: Developing Measures to Advance Access and Quality in Global Mental Health Services (R34 Clinical Trial Not Allowed)
- PAR-23-148: Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)
- PAR-23-152: Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)
- PAR-23-153: Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)
- RFA-OD-23-015: Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional)
- RFA-CA-23-023: Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional)
- RFA-MH-23-260: Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
- RFA-RM-23-007: NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
- RFA-AI-23-022: Animal Models for Hepatitis B and C (R01 Clinical Trial Not Allowed)
- PAR-23-132: NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
- PAR-23-133: NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)
- RFA-RM-23-005: NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
- RFA-NS-23-021: Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)
- RFA-NS-23-022: Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)
- RFA-RM-23-006: NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
- RFA-AI-23-018: Defining Mechanisms of HIV Induced Inflammation and Immune Activation During Suppressive Antiretroviral Therapy (ART) (R01 Clinical Trial Not Allowed)
- RFA-RM-23-002: Integration and Coordination Center for the Common Fund Data Ecosystem (U54 Clinical Trial Not Allowed)
- RFA-CA-23-028: Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
- RFA-RM-23-008: Limited Competition: Molecular Transducers of Physical Activity Bioinformatics Center (U24 Clinical Trial Not Allowed)
- RFA-RM-23-009: Limited Competition: Molecular Transducers of Physical Activity Chemical Analysis Sites (U24 Clinical Trial Not Allowed)
- RFA-RM-23-010: Limited Competition: Molecular Transducers of Physical Activity Clinical Centers (U01 Clinical Trial Required)
- RFA-RM-23-011: Limited Competition: Molecular Transducers of Physical Activity Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
- PAR-23-139: CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)
- RFA-MH-23-140: Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
- RFA-ES-23-008: Novel Approaches for Developmental Neurotoxicity Testing (R43/R44 Clinical Trial Not Allowed)
- PAR-23-138: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)
- PAR-23-269: NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)
- PAR-22-265: Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)
- PAR-23-113: NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
- PAR-23-128: Biological Testing Facility (X01 Clinical Trial Not Allowed)
- PA-23-134: NIH Administrative Supplements to Recover Losses due to Hurricanes Fiona and Ian Under the Consolidated Appropriations Act, 2023 (Admin Supp Clinical Trial Optional)
- RFA-RM-23-004: NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
- RFA-AI-23-019: Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed)
- RFA-AI-23-020: Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed)
- RFA-AI-23-021: Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed)
- PAR-23-122: Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
- PAR-23-123: Entry-Level Modules (ELM) for Training the Genomics Research Workforce (R25-Clinical Trial Not Allowed)
- RFA-AG-24-004: Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial Not Allowed)
- RFA-AG-24-010: Limited Competition: The Health and Retirement Study and Harmonized Cognitive Assessment Protocol (U01 Clinical Trial Not Allowed)
- RFA-CA-23-031: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)
- PAR-23-140: Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed)
- RFA-EB-23-002: NIBIB Biomaterials Network Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
- RFA-NS-24-004: BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
- RFA-NS-24-005: BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
- RFA-AG-24-009: Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)
- PAR-23-125: Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)
- RFA-HD-24-008: Population Dynamics Centers Research Infrastructure Program FY 2024 (P2C Clinical Trial Not Allowed)
- PAR-23-127: Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trials Not Allowed)
- RFA-AG-24-012: NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 - Independent Clinical Trial Not Allowed)
- RFA-AG-24-013: NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 - Independent Clinical Trial Not Allowed)
- RFA-OD-23-013: Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional)
- RFA-CA-23-025: Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required)
- PAR-23-109: NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)
- PAR-23-116: Centers for AIDS Research (P30 Clinical Trial Not Allowed)
- PAR-23-117: Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
- RFA-OD-23-014: Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional)
- PAR-23-110: Biomedical Technology Optimization and Dissemination Center (BTOD)(RM1-Clinical Trial Not Allowed)
- PAR-23-118: National Centers for Cryoelectron Microscopy (R24 Clinical Trial Not Allowed)
- RFA-ES-23-005: SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
- PAR-23-129: Coordination Center for the Models of Infectious Disease Agent Study (MIDAS) Program (R24 Clinical Trial Not Allowed)
- PAR-23-265: NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed)
- PAR-23-263: NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed)
- PAR-23-266: NIMH Research Education Programs for Psychiatry Residents (R25- Independent Clinical Trial Not Allowed)
- RFA-AG-24-008: Edward R. Roybal Coordinating Center (R24 - Clinical Trial Not Allowed)
- RFA-AG-24-007: Roybal Centers for Translational Behavioral Research on Dementia Care, Caregiver Support, and Prevention of Alzheimers Disease and Related Dementias (AD/ADRD) (P30 Clinical Trial Required)
- RFA-AG-24-006: Roybal Centers for Translational Research on Aging (P30 Clinical Trial Required)
- RFA-ES-23-007: Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)
- PAR-23-130: Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
- PAR-23-131: Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
- PAR-23-124: Genomic Community Resources (U24 Clinical Trial Not Allowed)
- RFA-DA-24-001: Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed)
- RFA-NR-23-003: Evaluating the Impact of Pandemic Era related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)
- RFA-NR-23-002: Advancing Integrated Models (AIM) of Care to Improve Pregnancy Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Optional)
- RFA-NR-23-004: Clinical-Community Linkages to Address Social Needs and Social Conditions to Advance Health Equity among Populations Experiencing Health Disparities: The Bridge-to-Care Initiative (R01 Clinical Trial Required)
- RFA-MH-23-275: Using Secondary Data Analysis to Determine Whether Preventive Interventions Implemented Earlier in Life Reduce Suicide Risk (U01 Clinical Trial Not Allowed)
- RFA-DK-22-037: Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 Independent Clinical Trial not Allowed)
- RFA-AT-24-001: Research Network to Promote Multidisciplinary Mechanistic and Translational Studies of Sickle Cell Disease Pain (U24, Clinical Trial Optional)
- PAR-23-121: Limited Competition: NIDDK Program Projects (P01 Clinical Trial Optional)
- RFA-AG-24-014: Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed)
- RFA-AG-24-015: Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required)
- RFA-DA-24-008: Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 Clinical Trials Not Allowed)
- RFA-DA-24-009: Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 Clinical Trials Not Allowed)
- RFA-AI-23-015: Genomics Centers for Infectious Diseases (U19 Clinical Trial Not Allowed)
- RFA-ES-23-003: Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed)
- RFA-MD-23-004: Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional)
- RFA-NS-24-018: HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)
- PAR-23-106: Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
- PAR-23-099: Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
- RFA-DK-22-038: Pilot Interventions to Integrate Social Care and Medical Care to Improve Health Equity (R01 Clinical Trial Required)
- RFA-MD-23-008: Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional)
- RFA-MD-23-007: Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required)
- RFA-AG-24-019: Comparative Research on Determinants of Differences Among Human and Nonhuman Primate Species in Life Spans, Life Histories, and Other Aging-Related Outcomes, and Prospects for Translation (R01 Clinical Trial Not Allowed)
- RFA-AG-24-020: Networking/Infrastructure Project for Research on Determinants of Differences Among Human and Nonhuman Primate Species in Life Spans, Life Histories, and Other Aging Related Outcomes, and Prospects for Translation (R61/R33 Clinical Trial Not Allowed)
- RFA-DK-23-006: Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)
- PAR-23-100: IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional)
- RFA-AI-23-008: Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U01 Clinical Trial Not Allowed)
- RFA-NS-24-001: Using Multimodal Biomarkers to Differentially Diagnose ADRDs for Clinical Trials (U19 Clinical Trial Optional)
- RFA-AG-24-011: Research Coordinating Center on the Exposome and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD): Elucidating the Role of Social and Behavioral Determinants of Health in AD/ADRD Etiology and Disparities (U24 Clinical Trial Not Allowed)
- PAR-23-090: NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
- RFA-DA-24-027: Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed)
- RFA-AI-22-076: Consortium for Food Allergy Research: Clinical Research Center (U01 Clinical Trial Required)
- RFA-AI-22-077: Consortium for Food Allergy Research: Leadership Center (UM1 Clinical Trial Required)
- RFA-DA-24-037: Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
- RFA-DK-22-511: Limited Competition for the Continuation of the Rare and Atypical Diabetes NeTwork (RADIANT) Specialized Study Centers (U54 - Clinical Trial Not Allowed)
- PAR-23-035: Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
- RFA-OD-23-004: Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U24 Clinical Trial Not Allowed)
- PAR-23-077: Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)
- PAS-23-086: Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
- RFA-EB-23-001: Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)
- PAR-23-111: NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
- PAR-22-262: Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)
- RFA-AG-24-018: Team Science Approaches Integrating Experimental and Computational Brain Aging Models (R21/R33 Clinical Trial Not Allowed)
- PAR-23-089: Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed)
- PAR-23-107: Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Required)
- PAR-23-108: Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Not Allowed)
- PAR-23-112: Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
- RFA-MD-23-002: Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
- RFA-MD-23-003: Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
- PA-23-048: Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
- RFA-ES-23-004: Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
- PA-23-080: Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
- PAR-23-087: Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
- PAR-23-101: Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
- PAR-23-102: Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
- PAR-23-103: Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required )
- PAR-23-104: Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required)
- PAR-23-105: Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
- PAR-23-076: NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
- PAR-23-084: Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
- RFA-MH-23-170: Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required)
- PAR-23-074: In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
- RFA-AG-24-001: Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)
- RFA-ES-23-002: Accelerating Data and Metadata Standards in the Environmental Health Sciences (R24 Clinical Trial Not Allowed)
- PAR-23-064: NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
- PAR-23-082: Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
- PAR-23-073: Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed)
- RFA-HL-24-003: Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Coordination Center (U24 Clinical Trial Not Allowed)
- RFA-HL-24-004: Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed)
- RFA-AG-24-002: Renewal of the Interventions Testing Program (U01 Clinical Trial Not Allowed)
- RFA-AG-24-003: Interventions Testing Program (ITP) Data Coordinating Center (U24 Clinical Trial Not Allowed)
- RFA-DE-23-014: Planning for the TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (R34 Clinical Trial Not Allowed)
- RFA-HL-24-001: Pediatric Heart Network Clinical Research Centers (UM1 Clinical Trial Optional)
- RFA-HL-24-002: Limited Competition: Pediatric Heart Network for the Data Coordinating Center (U24 Clinical Trial Not Allowed)
- PAR-23-060: Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
- PAR-23-061: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
- PAR-23-062: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
- RFA-OD-23-001: Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed)
- PAR-23-071: NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
- PAR-23-070: NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
- RFA-NS-23-012: Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- PAR-22-261: Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
- RFA-NS-23-002: Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging findings in TBI-related dementia and/or VCID (U24 - Clinical Trials Not Allowed)
- PAR-23-088: Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
- PAR-23-096: Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
- PAR-23-091: Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
- PAR-23-093: Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
- PAR-23-092: Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional)
- PAR-23-097: Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
- PAR-23-094: Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required)
- PAR-23-095: Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)
- RFA-EB-22-003: BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed)
- RFA-DK-22-028: Pilot and Feasibility Trials on the Integration of Social and Medical Care for Type 1 Diabetes Mellitus (R01 Clinical Trial Required)
- RFA-MD-23-001: Research Centers in Minority Institutions (RCMI) (U54 Clinical Trial Optional)
- PAR-23-069: HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed)